Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform Business Wire Kite sails into in vivo CAR-T space via $350M Interius buyout Fierce Biotech Gilead’s Kite Pharma acquires Interius BioTherapeutics for $350 million statnews.com Gilead Sciences to Buy Interius BioTherapeutics for $350 Million MarketScreener Gilead’s Kite buying Interius BioTherapeutics for $350M Seeking Alpha Source link
Read More »Tag Archives: BioTherapeutics
Nasdaq-listed Sonnet BioTherapeutics agrees to $888 million merger to become Hyperliquid Strategies, launch HYPE treasury – The Block
Nasdaq-listed Sonnet BioTherapeutics agrees to $888 million merger to become Hyperliquid Strategies, launch HYPE treasury The Block Massive $888M Deal: Biotech Firm Makes Historic Pivot to Become Largest US Public HYPE Token Holder Stock Titan Sonnet BioTherapeutics jumps over 320%, combines business for HYPE crypto reserve (SONN:NASDAQ) Seeking Alpha Sonnet BioTherapeutics, Inc. Announces $888 Million GlobeNewswire Why Is Sonnet BioTherapeutics Stock (SONN) Up 180% …
Read More »Sonnet BioTherapeutics, Inc. Announces $888 Million
PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that it has entered into a definitive agreement (the “Business Combination Agreement”, or the “BCA”) for a business combination (the “Business Combination”) with Rorschach I LLC (“Rorschach”), a newly-formed entity formed by an entity affiliated with Atlas Merchant Capital LLC (“Atlas”), …
Read More »